This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan DDIT4 IHC in paraffin sections using reported cytoplasmic tissue staining as a reference (HPA tissue IHC). Compare matched sections under consistent fixation and score staining by cell type and intensity (standard IHC practice).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Cytoplasmic tissue staining (HPA tissue IHC) | |
| Staining pattern | Glandular-cell cytoplasmic staining; texture unreported (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6.0 HIER, 95–98 °C, 20 min (rule: cytoplasmic / membrane antigen) | |
| Positive control | Adrenal gland+4 more · see all | |
| Negative control | Adipose tissue |
| Fixation | Keep fixation conditions consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Staining and RNA show only medium consistency (HPA tissue IHC) | |
| Regulation | Responds to hypoxia and DNA damage (UniProt) | |
| Isoform / epitope | No annotated isoforms or processing changes (UniProt) |
The catalog antibody’s IHC-P protocol accompanies published DDIT4 methods for lung adenocarcinoma (PMC8489140) and gastric cancer tissue microarrays (PMC11929655).
| Sample | Tissue sections; selected-image fixative not specified (standard IHC workflow) |
| Fixation | Image fixative and duration unreported (datasheet A02019); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in citrate buffer, pH 6.0, 20 min at 95–98 °C (standard rule: cytoplasmic / membrane antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit anti-DDIT4, 5 μg/mL (datasheet A02019) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DDIT4-positive staining in glandular cells of adrenal gland (HPA tissue IHC: High). HPA tissue profile: General cytoplasmic expression. No signal in the no-primary control. |
DDIT4 should show predominantly cytoplasmic staining in paraffin sections (HPA: general cytoplasmic expression), consistent with its cytosolic and mitochondrial annotations (UniProt Q9NX09). Expect strong staining in selected glandular and hematopoietic cells, and colonic endothelial cells (HPA: High). Interpret intensity by cell type: HPA rates the tissue IHC evidence Approved, with medium consistency between antibody staining and RNA expression (HPA: reliability summary). DDIT4 has no transmembrane segment (UniProt Q9NX09 topology).
| Cytoplasmic staining is prominent in adrenal or breast glandular cells, or bone marrow hematopoietic cells (HPA: High). | This matches reported high-staining cell types and the general cytoplasmic profile (HPA: tissue IHC). Compare cells within the same section; high staining is not expected in every cell (HPA: tissue IHC). |
| Staining is predominantly nuclear or outlines cell membranes, with little cytoplasmic signal. | That distribution conflicts with HPA's cytoplasmic profile and UniProt's cytosolic and mitochondrial annotations (HPA: tissue IHC; UniProt Q9NX09). Review staining specificity and detection conditions using general IHC controls. |
| Adipocytes stain strongly, while an adjacent expected positive cell population is weak or unstained. | HPA reports DDIT4 as not detected in adipocytes (HPA: adipose tissue). The reversal raises concern for nonspecific antibody binding or endogenous detection activity; assess appropriate controls before assigning a DDIT4-positive result. |
| Most structures show a uniform haze that obscures cell boundaries. | Diffuse, non-cell-resolved color does not establish the reported cytoplasmic distribution (HPA: tissue IHC). In general IHC practice, background can arise from detection reagents, insufficient blocking or overly strong staining. |
| A control section from a reported high-staining tissue has no visible cytoplasmic signal. | Check that the section contains the relevant cell type: HPA's High call is cell-specific (HPA: tissue IHC). If it does, review the antibody and general IHC workflow before interpreting the test section as negative. |
| Which cells provide a useful positive comparison? | HPA reports High staining in adrenal, appendix, breast, cervix, duodenal and endometrial glandular cells; bone marrow hematopoietic cells; and colonic endothelial cells (HPA: tissue IHC). Select a section containing the specified cells. |
| How should a weak or absent cell population be judged? | Adipocytes are reported not detected, whereas liver cholangiocytes are listed as low (HPA: tissue IHC). These are cell-specific observations, not guarantees for every section; HPA rates overall staining/RNA consistency as medium (HPA: reliability summary). |
| Does DDIT4 topology predict membrane staining? | DDIT4 has no transmembrane segment or signal peptide, and its annotated chain spans residues 1–232 (UniProt Q9NX09). These annotations support checking a membrane-only pattern carefully; they do not establish antigen retrieval or fixation sensitivity. |
| How strong is the antibody validation evidence? | Two listed antibodies have IHC status Approved (HPA: HPA034507, HPA034508). Treat this as the stated validation level; the supplied antibody summary does not label either IHC result Enhanced (HPA: antibody validation). |
| What should IF/ICC show? | HPA reports supported cytosolic localization and ICC support for HPA034508 (HPA: subcellular atlas; antibody validation). Use that localization as a cross-check of compartment, while consulting the separate IF/ICC guide for experimental design. |
| Situation | Likely cause | Next action |
|---|---|---|
| No signal in the selected positive control cells. | The sampled cells may differ from HPA's specified High population (HPA: tissue IHC), or a general IHC workflow step may have failed. | Confirm cell identity and control quality first. Then check primary-antibody application, detection reagents and counterstain; optimize general IHC conditions with the control section before scoring unknown sections. |
| Nuclear staining dominates the section. | Predominantly nuclear signal conflicts with cytoplasmic tissue staining and supported cytosolic IF localization (HPA: tissue IHC; subcellular atlas). Its cause cannot be assigned from localization data alone. | Inspect a reported high-staining cell population and an appropriate negative reagent control. Reassess antibody specificity and detection background before counting nuclear color as DDIT4. |
| Adipocytes show stronger staining than the expected positive cells. | That contrast reverses the supplied adipocyte observation, which is not detected (HPA: adipose tissue), and may reflect nonspecific or endogenous detection signal. | Check reagent controls and examine whether color follows the expected cytoplasmic, cell-specific distribution (HPA: tissue IHC). Do not use adipocyte staining alone to validate a positive call. |
| The entire section has diffuse brown background. | Diffuse color prevents assessment of HPA's general cytoplasmic pattern (HPA: tissue IHC). General IHC causes include inadequate blocking, endogenous detection activity or excessive reagent concentration. | Use general IHC controls to locate the background source; adjust blocking, washes, antibody concentration or detection conditions as indicated. Re-evaluate the section for cell-resolved cytoplasmic staining. |
| Only membranes appear sharply stained. | A membrane-only pattern disagrees with HPA's cytoplasmic profile and DDIT4's lack of a transmembrane segment (HPA: tissue IHC; UniProt Q9NX09 topology). | Compare the same cell type with a reported positive tissue and review reagent controls. Resolve the compartment discrepancy before treating the membrane outline as target staining. |
| Staining varies across specimens of the same tissue. | HPA's levels describe particular cell types, and antibody staining has medium consistency with RNA data (HPA: tissue IHC; reliability summary). The supplied sources do not identify a DDIT4-specific fixation effect. | Score comparable cell populations and include a positive control in each run. Review general section preparation and detection consistency; avoid assigning a target-specific fixation cause without supporting evidence. |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Approved — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | Glandular cells | High | Protein (IHC) | HPA → |
| Appendix | Glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | Glandular cells | High | Protein (IHC) | HPA → |
| Cervix | Glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
Troubleshoot DDIT4 staining by checking cytoplasmic localisation, tissue controls and processing conditions before interpreting chromogenic signal (HPA tissue IHC; HPA subcellular).
A02019 has mouse kidney IHC and IF images (catalog image captions) and lists Human, Mouse, and Rat reactivity (catalog). The IHC application is IHC-P (catalog).
A02019 has a mouse kidney IHC image at 5 μg/mL (IHC image caption) and lists IHC-P (catalog). A02019 also has a mouse kidney IF image at 20 μg/mL (IF image caption) and lists Human, Mouse, and Rat reactivity (catalog).
Which to pick: For paraffin-section tissue IHC, choose A02019 because it lists IHC-P (catalog); its IHC image shows mouse kidney (IHC image caption), and the fixative is unreported (IHC image caption). For IF, choose A02019 based on its mouse kidney IF image (IF image caption); ICC validation is unreported (catalog). For work across species, A02019 lists Human, Mouse, and Rat reactivity (catalog), while the supplied IHC and IF images show mouse tissue (image captions).